Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20

1.

Modeling HIV infection and therapies in humanized mice.

Nischang M, Gers-Huber G, Audigé A, Akkina R, Speck RF.

Swiss Med Wkly. 2012 Jul 9;142:w13618. doi: 10.4414/smw.2012.13618. Review.

2.

Humanized mouse models of HIV-1 latency.

Duyne RV, Narayanan A, K-Hall K, Saifuddin M, Shultz L, Kashanchi F.

Curr HIV Res. 2011 Dec 1;9(8):595-605. Review.

PMID:
22211664
3.

Humanized mouse models of HIV infection.

Denton PW, García JV.

AIDS Rev. 2011 Jul-Sep;13(3):135-48. Review.

4.
5.

The SCID-hu mouse: a small animal model for the analysis of human hematolymphoid differentiation and function.

McCune JM.

Bone Marrow Transplant. 1992;9 Suppl 1:74-6. Review. No abstract available.

PMID:
1354528
6.

HIV-1 immunopathogenesis in humanized mouse models.

Zhang L, Su L.

Cell Mol Immunol. 2012 May;9(3):237-44. doi: 10.1038/cmi.2012.7. Epub 2012 Apr 16. Review.

7.

SCID-hu mice: a model for studying disseminated HIV infection.

Goldstein H, Pettoello-Mantovani M, Katopodis NF, Kim A, Yurasov S, Kollmann TR.

Semin Immunol. 1996 Aug;8(4):223-31. Review.

PMID:
8883145
8.
9.

The value of preserving HIV-specific immune responses.

Kaufmann DE, Rosenberg ES.

J HIV Ther. 2003 Feb;8(1):19-25. Review.

PMID:
12840711
10.

Novel humanized murine models for HIV research.

Denton PW, Garcia JV.

Curr HIV/AIDS Rep. 2009 Feb;6(1):13-9. Review.

11.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
12.

BLT humanized mice as model to study HIV vaginal transmission.

Deruaz M, Luster AD.

J Infect Dis. 2013 Nov;208 Suppl 2:S131-6. doi: 10.1093/infdis/jit318. Review.

13.

Modeling AIDS in a mouse.

Mosier DE.

Hosp Pract (1995). 1996 Sep 15;31(9):41-8, 53-5, 59-60. Review.

PMID:
8814120
14.

The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models.

Sato K, Koyanagi Y.

Exp Biol Med (Maywood). 2011 Aug;236(8):977-85. doi: 10.1258/ebm.2011.010294. Epub 2011 Jul 12. Review.

PMID:
21750016
15.

Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model.

Chang JJ, Altfeld M.

J Infect Dis. 2013 Nov;208 Suppl 2:S145-9. doi: 10.1093/infdis/jit402. Review.

16.

Development of antiviral treatment strategies in murine models.

Ruprecht RM, Koch JA, Sharma PL, Armany RS.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):997-1011. Review.

PMID:
1323985
17.

Overcoming current limitations in humanized mouse research.

Brehm MA, Shultz LD, Luban J, Greiner DL.

J Infect Dis. 2013 Nov;208 Suppl 2:S125-30. doi: 10.1093/infdis/jit319. Review.

18.

Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized mice.

Bennett MS, Akkina R.

Viruses. 2013 Dec 12;5(12):3119-41. doi: 10.3390/v5123119. Review.

19.

Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?

Gorantla S, Gendelman HE, Poluektova LY.

J Neuroimmune Pharmacol. 2012 Jun;7(2):352-62. doi: 10.1007/s11481-011-9335-y. Epub 2012 Jan 7. Review.

20.

Latest animal models for anti-HIV drug discovery.

Sliva K.

Expert Opin Drug Discov. 2015 Feb;10(2):111-23. doi: 10.1517/17460441.2015.975201. Epub 2014 Oct 28. Review.

PMID:
25350741
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk